Loading stock data…
Loading stock data…
US$68.28
Get one email when MRNA crosses your level. Checked every 15 minutes during market hours.
▲ +0.84 (1.25%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
54.7
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
4.44
Bearish momentumMACD below its signal line (5.50).
50-day average
56.47
Price aboveShort-term trend reference.
200-day average
43.02
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Moderna, Inc. is a biotechnology company specializing in the development of transformative medicines using messenger ribonucleic acid (mRNA) technology. Its primary focus lies in creating innovative therapeutics across multiple modalities, including prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology treatments, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics, and systemic intracellular therapeutics. The company advances respir…
www.modernatx.com0 strong buy · 4 buy · 19 hold · 4 sell · 3 strong sell (30 analysts, 2026-07-01)
0 strong buy · 4 buy · 19 hold · 4 sell · 3 strong sell (30 analysts, 2026-06-01)
2 strong buy · 7 buy · 18 hold · 2 sell · 1 strong sell (30 analysts, 2026-05-01)
0 strong buy · 3 buy · 21 hold · 3 sell · 3 strong sell (30 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-22 | 1.34 | 1.78 | ✓ Beat |
| 2026-05-01 | -3.96 | -1.18 | ✓ Beat |
| 2026-03-17 | 0.42 | 0.65 | ✓ Beat |
| 2026-03-04 | 0.06 | 0.15 | ✓ Beat |
| 2026-02-12 | 1.03 | 1.07 | ✓ Beat |
| 2025-11-06 | -2.16 | -0.51 | ✓ Beat |
| 2025-08-01 | -3 | -2.13 | ✓ Beat |
Companies in the same industry, via Finnhub